Soft tissue augmentation 2006: filler fantasy.

Area of Science:

• Dermatology
• Plastic Surgery
• Cosmetic Procedures

Background:

• Increasing patient demand for esthetic improvement via minimally invasive procedures.
• Botulinum toxin type A's success in upper facial rejuvenation drives interest in lower facial restoration.
• The concept of three-dimensional facial rejuvenation emphasizes soft, full contours over a flat appearance.

Purpose of the Study:

• To review the criteria for safe and effective soft tissue augmentation agents.
• To highlight the growing importance of minimally invasive techniques in facial esthetics.
• To emphasize the role of injectable fillers in lower facial and lip enhancement.

Main Methods:

• Review of current literature on soft tissue augmentation agents and techniques.
• Discussion of criteria for ideal filling agents: high use potential, low abuse potential, nonteratogenic, noncarcinogenic, nonmigratory.
• Emphasis on U.S. Food and Drug Administration (FDA) approval for safety and efficacy.

Main Results:

• Injectable fillers are the primary indication for lower facial rejuvenation, particularly lip enhancement.
• Minimally invasive soft tissue augmentation provides cosmetic benefits without extensive recovery.
• Physicians have a wider array of techniques and materials for facial contouring and wrinkle amelioration.

Conclusions:

• A thorough understanding of available filling agents, their indications, contraindications, and implantation techniques is vital.
• Safe and effective soft tissue augmentation requires adherence to established criteria and FDA approval.
• Minimally invasive procedures offer a valuable alternative for patients seeking facial esthetic improvements.